Disclosures
PLATFORM
¹ Some features may not be available in all regions or all languages.
² All pricing may not be available in all regions.
³ All U.S. Patent and Trademark Office employees are legally obligated to preserve pending applications for patents in confidence until they are published or patented in accordance with 35 U.S.C. 122 and 37 CFR 1.14.
PRODUCTS
⁴ Mobile App Usage Health Warning: WARNING: PHOTOSENSITIVITY/EPILEPSY SEIZURES
A very small percentage of individuals may experience epileptic seizures or blackouts when exposed to certain light patterns or flashing lights. Exposure to certain patterns or backgrounds on a television screen or when collecting data may trigger epileptic seizures or blackouts in these individuals. These conditions may trigger previously undetected epileptic symptoms or seizures in persons who have no history of prior seizures or epilepsy. AmniSphere Mobile App uses Flash from the mobile device to help collect dynamic data
⁵ Confidence, accuracy, and precision assurances of 99% are based on using our AI engine (AmniEngine) via API integration within our business subscription accounts. Achieving these levels of confidence is contingent upon utilizing our full ecosystem, including collecting object data with our mobile app using Amniscient's proprietary Generative AI Synthetic Data.
⁶ Run-time Models are tied to a subscription account. Run-time models have a life span of 30 days if the subscription is not renewed or expires.
⁷ Users must have a subscription account to AmniSphere and AmniGadget.
⁸ 3rd Party Applications running next to the Run-Time AI Models are limited to the Hardware Requirements of Amniscient's certified hardware. Not all certified hardware supports this feature. Running your applications and Run-time models simultaneously depends on CPU memory and available storage.